The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.50
Ask: 32.00
Change: -0.25 (-0.78%)
Spread: 0.50 (1.587%)
Open: 31.75
High: 31.75
Low: 31.75
Prev. Close: 32.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Contribution to Royalty Partner

28 Sep 2018 07:00

RNS Number : 2357C
Duke Royalty Limited
28 September 2018
 

28 September 2018

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

£1 million follow-on contribution to Lynx Equity (U.K.) Limited

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has contributed a further £1 million into its existing royalty partner, Lynx Equity (U.K.) Limited ("Lynx UK").

 

Lynx UK will allocate Duke's further contribution towards the acquisition of Day 2 Interiors ("Day2") which was recently closed by Lynx and represents its fourth European acquisition.

 

Based on the new increased aggregate investment of £10 million, Duke will be entitled to higher monthly distributions from Lynx UK, beginning in October 2018, which will total £1.25 million per annum. The terms of the additional £1 million contribution match the previous investments made into Lynx UK.

 

Founded in 2001, Day2 is a 17-year-old profitable UK private company primarily focused on the supply of office furniture and interior design in the UK. Day2 represents the biggest investment made by Lynx UK to date and further strengthens the Company's consolidated profitability as well as the sector diversification amongst its underlying operating subsidiaries.

 

Neil Johnson, CEO of Duke Royalty, said:

 

"We are delighted with this investment because it significantly improves Duke's coverage ratio as well as its security package. Day2 represents the biggest investment made by Lynx UK to date, and we believe the Company will provide robust, stable and long term returns to our shareholders."

 

Duke Royalty Portfolio

Following the completion of the follow-on contribution to Lynx UK, the Company's portfolio of royalty investments is as follows with over £43 million of capital deployed to date:

 

 

Royalty Partner

Current Royalty Investment Amount

Date of Original Royalty Agreement

Temarca B.V

Euro 9,000,000

April 2017

Lynx Equity (UK) Limited

GBP 10,000,000

October 2017

Trimite Global Coatings Limited

GBP 9,000,000

March 2018

Brownhills Investments Limited

GBP 6,500,000

April 2018

Interhealth Canada Holding Corp

GBP 10,000,000

August 2018

 

***ENDS***

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson/ Charlie Cannon-Brookes

 

+44 (0) 1481 741 240

Grant Thornton UK LLP 

(Nominated Adviser)

Colin Aaronson/ Samantha

Harrison

 

+44 (0) 20 7383 5100

 

Cenkos Securities plc 

(Joint Broker)

 

Julian Morse/ Michael Johnson

+44 (0) 207 397 8900

Mirabaud Securities Limited

(Joint Broker)

 

Peter Krens/ Edward Haig-Thomas

 

+44 (0) 20 3167 7222

Redleaf Communications

(PR)

 

Elisabeth Cowell/ Ian Silvera/ Tom Carnegie

+44 (0) 20 3757 6880

Dukeroyalty@redleafpr.com

 

About Duke Royalty

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

About Lynx UK

Lynx UK is a subsidiary of Lynx Equity which is a Toronto-based private firm that seeks to acquire, own and operate mature, old-economy businesses in a diverse range of industries. Over its 10-year history, Lynx has made over 45 acquisitions and grown revenue to over C$400 million per annum for its financial year ended 31 July 2017.

 

Lynx has been recognized as one of Canada's Fastest-Growing Companies three years in a row in the PROFIT 500, the definitive ranking published by Canadian Business magazine based on five-year revenue growth. Day2 is a London based furniture dealership, that provides consultancy, procurement and installation services to organisations of all shapes and sizes. The company is committed to providing a tailored service to every one of their clients, focusing on innovation, integrity and the highest levels of customer services.

 

For further information on Lynx Equity, please visit www.lynxequity.com

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKNXAESPEFF
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.